Total Payments
$4,146
2024 Payments
$1,233
Companies
20
Transactions
240
Medicare Patients
680
Medicare Billing
$166,169
Payment Breakdown by Category
Food & Beverage$4,092 (98.7%)
Education$53.75 (1.3%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,092 | 238 | 98.7% |
| Education | $53.75 | 2 | 1.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc. | $659.90 | 64 | $0 (2024) |
| ABBVIE INC. | $562.20 | 36 | $0 (2024) |
| Alkermes, Inc. | $558.36 | 26 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $350.67 | 10 | $0 (2024) |
| Otsuka America Pharmaceutical, Inc. | $347.55 | 21 | $0 (2024) |
| ITI, Inc. | $256.59 | 14 | $0 (2023) |
| Lundbeck LLC | $223.15 | 11 | $0 (2024) |
| Axsome Therapeutics, Inc. | $202.03 | 5 | $0 (2024) |
| Teva Pharmaceuticals USA, Inc. | $197.71 | 13 | $0 (2024) |
| Sunovion Pharmaceuticals Inc. | $177.11 | 13 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,233 | 54 | Otsuka America Pharmaceutical, Inc. ($206.85) |
| 2023 | $1,158 | 54 | ABBVIE INC. ($205.09) |
| 2022 | $849.62 | 42 | Alkermes, Inc. ($243.08) |
| 2021 | $906.25 | 90 | Takeda Pharmaceuticals U.S.A., Inc. ($442.76) |
All Payment Transactions
240 individual payment records from CMS Open Payments — Page 1 of 10
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug) | Food and Beverage | In-kind items and services | $27.66 | General |
| Category: Neuroscience | ||||||
| 12/17/2024 | Teva Pharmaceuticals USA, Inc. | UZEDY (Drug) | Food and Beverage | In-kind items and services | $5.18 | General |
| Category: Neurology | ||||||
| 12/13/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $19.30 | General |
| Category: Central Nervous System | ||||||
| 12/05/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $17.42 | General |
| Category: Neuropsychiatry | ||||||
| 12/03/2024 | Otsuka America Pharmaceutical, Inc. | ABILIFY ASIMTUFII (Drug) | Food and Beverage | In-kind items and services | $9.35 | General |
| Category: PSYCHIATRY | ||||||
| 11/26/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $11.60 | General |
| Category: PSYCHIATRY | ||||||
| 11/20/2024 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug) | Food and Beverage | In-kind items and services | $15.93 | General |
| Category: Neuroscience | ||||||
| 11/19/2024 | Teva Pharmaceuticals USA, Inc. | UZEDY (Drug) | Food and Beverage | In-kind items and services | $10.75 | General |
| Category: Neurology | ||||||
| 11/15/2024 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $32.39 | General |
| Category: CNS | ||||||
| 11/12/2024 | Otsuka America Pharmaceutical, Inc. | ABILIFY ASIMTUFII (Drug) | Food and Beverage | In-kind items and services | $8.42 | General |
| Category: PSYCHIATRY | ||||||
| 11/07/2024 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug) | Food and Beverage | In-kind items and services | $19.47 | General |
| Category: Neuroscience | ||||||
| 11/05/2024 | E.R. Squibb & Sons, L.L.C. | — | Food and Beverage | Cash or cash equivalent | $16.91 | General |
| 10/31/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $17.24 | General |
| Category: Central Nervous System | ||||||
| 10/29/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $21.16 | General |
| Category: PSYCHIATRY | ||||||
| 10/16/2024 | Otsuka America Pharmaceutical, Inc. | ABILIFY ASIMTUFII (Drug) | Food and Beverage | In-kind items and services | $8.67 | General |
| Category: PSYCHIATRY | ||||||
| 10/10/2024 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $28.55 | General |
| Category: CNS | ||||||
| 10/08/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $8.39 | General |
| Category: Central Nervous System | ||||||
| 10/02/2024 | Otsuka America Pharmaceutical, Inc. | ABILIFY ASIMTUFII (Drug) | Food and Beverage | In-kind items and services | $7.54 | General |
| Category: PSYCHIATRY | ||||||
| 09/12/2024 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $23.98 | General |
| Category: CNS | ||||||
| 09/05/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $24.48 | General |
| Category: NEUROSCIENCE | ||||||
| 08/29/2024 | Otsuka America Pharmaceutical, Inc. | ABILIFY ASIMTUFII (Drug) | Food and Beverage | In-kind items and services | $23.09 | General |
| Category: PSYCHIATRY | ||||||
| 08/22/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $17.36 | General |
| Category: Psychology/Psychiatric | ||||||
| 08/13/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $19.59 | General |
| Category: PSYCHIATRY | ||||||
| 08/13/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $8.08 | General |
| Category: Central Nervous System | ||||||
| 08/08/2024 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug) | Food and Beverage | In-kind items and services | $29.23 | General |
| Category: Neuroscience | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 3 | 183 | 720 | $126,180 | $38,388 |
| 2022 | 5 | 281 | 1,006 | $295,080 | $71,459 |
| 2021 | 4 | 119 | 417 | $135,040 | $34,508 |
| 2020 | 3 | 97 | 297 | $53,475 | $21,814 |
Total Patients
680
Total Services
2,440
Medicare Billing
$166,169
Procedure Codes
15
All Medicare Procedures & Services
15 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 86 | 353 | $82,128 | $22,817 | 27.8% |
| 90833 | Psychotherapy with evaluation and management visit, 30 minutes | Office | 2023 | 75 | 317 | $36,053 | $13,571 | 37.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 22 | 50 | $7,999 | $2,000 | 25.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 99 | 500 | $172,500 | $43,876 | 25.4% |
| 99308 | Follow-up nursing facility visit per day, typically 15 minutes | Facility | 2022 | 62 | 294 | $64,680 | $14,689 | 22.7% |
| 90833 | Psychotherapy with evaluation and management visit, 30 minutes | Office | 2022 | 62 | 121 | $27,225 | $6,105 | 22.4% |
| 99306 | Initial nursing facility visit per day, typically 45 minutes | Facility | 2022 | 27 | 31 | $16,275 | $3,470 | 21.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 31 | 60 | $14,400 | $3,318 | 23.0% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 57 | 314 | $108,330 | $28,030 | 25.9% |
| 90833 | Psychotherapy performed with evaluation and management visit, 30 minutes | Office | 2021 | 35 | 58 | $13,050 | $2,944 | 22.6% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 16 | 34 | $8,160 | $1,997 | 24.5% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Office | 2021 | 11 | 11 | $5,500 | $1,537 | 27.9% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 55 | 242 | $45,650 | $18,457 | 40.4% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 29 | 42 | $4,900 | $1,845 | 37.7% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Office | 2020 | 13 | 13 | $2,925 | $1,512 | 51.7% |
About Nancy Rehfeld
Nancy Rehfeld is a Family healthcare provider based in Glendora, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/29/2015. The National Provider Identifier (NPI) number assigned to this provider is 1093198848.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Nancy Rehfeld has received a total of $4,146 in payments from pharmaceutical and medical device companies, with $1,233 received in 2024. These payments were reported across 240 transactions from 20 companies. The most common payment nature is "Food and Beverage" ($4,092).
As a Medicare-enrolled provider, Rehfeld has provided services to 680 Medicare beneficiaries, totaling 2,440 services with total Medicare billing of $166,169. Data is available for 4 years (2020–2023), covering 15 distinct procedure/service records.
Ad
Practice Information
- Specialty Family
- Location Glendora, CA
- Active Since 06/29/2015
- Last Updated 09/15/2020
- Taxonomy Code 363LF0000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1093198848
Products in Payments
- TRINTELLIX (Drug) $659.90
- VRAYLAR (Drug) $562.20
- ARISTADA (Drug) $437.60
- REXULTI (Drug) $363.86
- CAPLYTA (Drug) $297.61
- Auvelity (Drug) $202.03
- INVEGA SUSTENNA (Drug) $187.33
- LATUDA (Drug) $177.11
- SPRAVATO (Drug) $163.34
- COBENFY (Drug) $149.26
- QELBREE (Drug) $136.74
- ABILIFY MAINTENA (Drug) $129.24
- Austedo XR (Drug) $126.02
- LYBALVI (Drug) $120.76
- QUVIVIQ (Drug) $88.60
- ABILIFY ASIMTUFII (Drug) $63.35
- HETLIOZ (Drug) $52.25
- Dyanavel XR (Drug) $45.63
- PERSERIS (Drug) $37.01
- AUSTEDO (Drug) $36.38
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Doctors in Glendora
Steve Yang, Np, NP
Family — Payments: $9,887
Family $9,887
Chelsea Fujita-Haffner, Np-C, NP-C
Family — Payments: $7,221
Family $7,221
Shuyan Liu, Np, NP
Family — Payments: $3,032
Family $3,032
Ms. Kelly Sharkey, Np-C, NP-C
Family — Payments: $2,145
Family $2,145
Jennifer Anotado, Rn Fnp, RN FNP
Family — Payments: $1,696
Family $1,696
Beth Bergman, Msn, Rn, Apn-C, MSN, RN, APN-C
Family — Payments: $737.57
Family $737.57